Family and Caregiver Characteristics Contribute to Caregiver Change in Use of Strategies and Growth in Child Spoken Language in a Parent-Implemented Language Intervention in Fragile X Syndrome.
Journal
Perspectives of the ASHA special interest groups
ISSN: 2381-4764
Titre abrégé: Perspect ASHA Spec Interest Groups
Pays: United States
ID NLM: 101682248
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
entrez:
13
2
2023
pubmed:
14
2
2023
medline:
14
2
2023
Statut:
ppublish
Résumé
This study examined relationships among family characteristics, caregiver change in use of strategies, and child growth in spoken language over the course of a parent-implemented language intervention (PILI) that was developed to address some of the challenges associated with the fragile X syndrome (FXS) phenotype. Participants were 43 parent-child dyads from two different PILI studies, both of which taught parents various language facilitation strategies to support child language. Before starting the intervention, parents reported on their mental health, parenting stress, and parenting competence. This study focused on potential barriers to treatment gains by examining correlations between the measures of parent well-being and (a) parent change in use of intervention strategies taught in the PILI and (b) changes in child language outcomes from preto post-intervention. Parents in this study had elevated mental health symptoms across several domains and increased rates of parenting stress. Furthermore, although PILI resulted in treatment gains for both parents and children, a variety of parent mental health symptoms were found to be significantly and negatively associated with change in use of strategies and growth in child language over the course of the intervention. Some inconsistent findings also emerged regarding the relationships between parenting stress and competence and change in parent strategy use and growth in child language. This study provides preliminary evidence that parents who are experiencing significant mental health challenges may have a more difficult time participating fully in PILIs and that there may be subsequent effects on child outcomes. Future PILIs could benefit from addressing parent well-being as a substantial part of the intervention program.
Identifiants
pubmed: 36778100
doi: 10.1044/2022_persp-22-00016
pmc: PMC9910303
mid: NIHMS1869895
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1630-1644Subventions
Organisme : NICHD NIH HHS
ID : P50 HD103526
Pays : United States
Déclaration de conflit d'intérêts
Disclosure: The authors have declared that no competing financial or nonfinancial interests existed at the time of publication.
Références
Clin Child Fam Psychol Rev. 2012 Sep;15(3):247-77
pubmed: 22869324
Res Dev Disabil. 2019 Jun;89:76-82
pubmed: 30959430
Am J Med Genet. 2002 Mar 1;108(2):105-16
pubmed: 11857559
J Autism Dev Disord. 2015 Sep;45(9):2816-32
pubmed: 25904201
Mindfulness (N Y). 2019 Jun;10(6):1017-1030
pubmed: 31191735
Am J Speech Lang Pathol. 2016 Feb;25(1):46-66
pubmed: 26502382
J Neurodev Disord. 2020 Mar 24;12(1):10
pubmed: 32204695
Res Dev Disabil. 2006 Nov-Dec;27(6):688-704
pubmed: 16361079
J Appl Res Intellect Disabil. 2014 Mar;27(2):174-86
pubmed: 23813562
J Commun Disord. 2018 Mar - Apr;72:64-76
pubmed: 29494850
Front Psychiatry. 2021 Nov 24;12:716585
pubmed: 34899411
Am J Intellect Dev Disabil. 2016 May;121(3):236-65
pubmed: 27119214
Fam Relat. 2012 Apr 1;61(2):327-342
pubmed: 22611299
J Speech Lang Hear Res. 2010 Oct;53(5):1334-48
pubmed: 20643789
Ment Retard Dev Disabil Res Rev. 2007;13(4):330-8
pubmed: 17979201
Intellect Dev Disabil. 2020 Dec 1;58(6):525-531
pubmed: 33290532
J Speech Lang Hear Res. 2013 Feb;56(1):295-309
pubmed: 22744141
Am J Med Genet B Neuropsychiatr Genet. 2013 Jul;162B(5):466-73
pubmed: 23740716
Front Psychiatry. 2018 Nov 13;9:564
pubmed: 30483160
J Neurodev Disord. 2020 Apr 22;12(1):12
pubmed: 32316911
J Child Psychol Psychiatry. 2009 Mar;50(3):254-62
pubmed: 19175819
Brain Sci. 2019 Jan 12;9(1):
pubmed: 30642066
J Dev Behav Pediatr. 2003 Aug;24(4):267-75
pubmed: 12915799
J Neurodev Disord. 2011 Mar;3(1):57-67
pubmed: 21475730
Am J Ment Retard. 2004 May;109(3):237-54
pubmed: 15072518
Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1139-1147
pubmed: 27615674
J Atten Disord. 2019 Jan;23(2):181-188
pubmed: 25731183
J Speech Lang Hear Res. 2006 Jun;49(3):466-85
pubmed: 16787891
Am Psychol. 2020 Nov;75(8):1093-1104
pubmed: 33252947
Autism Dev Lang Impair. 2017 Jan-Dec;2:
pubmed: 30417116
Neuron. 2013 Jan 23;77(2):243-50
pubmed: 23352161
Dev Neurorehabil. 2018 Jan;21(1):48-63
pubmed: 28956679
Dev Neuropsychol. 2003;24(2-3):559-91
pubmed: 14561562
J Autism Dev Disord. 2019 Mar;49(3):960-977
pubmed: 30382442
Genet Med. 2001 Sep-Oct;3(5):359-71
pubmed: 11545690
Am J Intellect Dev Disabil. 2013 Jul;118(4):310-26
pubmed: 23937372
Autism. 2017 Jan;21(1):5-17
pubmed: 26951325
Ment Retard Dev Disabil Res Rev. 2007;13(1):36-46
pubmed: 17326110
Autism. 2016 Oct;20(7):845-55
pubmed: 26862084
Matern Child Health J. 2019 Jul;23(7):971-978
pubmed: 30649661
Front Public Health. 2020 Apr 28;8:128
pubmed: 32411643
J Neurodev Disord. 2014;6(1):30
pubmed: 25097672
J Neurodev Disord. 2020 Nov 20;12(1):31
pubmed: 33218305
JMIR Ment Health. 2020 Mar 26;7(3):e18848
pubmed: 32213476
Autism. 2015 Apr;19(3):259-61
pubmed: 25950033
Am J Med Genet A. 2014 Jul;164A(7):1648-58
pubmed: 24700618
J Intellect Disabil Res. 2007 Jun;51(Pt. 6):447-62
pubmed: 17493028
Hum Mol Genet. 2003 Oct 15;12 Spec No 2:R249-57
pubmed: 12952862
Am J Med Genet. 2001 Nov 1;103(4):314-9
pubmed: 11746012
Expert Rev Med Devices. 2021 Dec;18(sup1):37-49
pubmed: 34872429
J Intellect Disabil Res. 2016 Jan;60(1):54-67
pubmed: 26449367
J Neurodev Disord. 2009 Mar;1(1):33-45
pubmed: 19865612
Front Psychiatry. 2022 Apr 01;13:857633
pubmed: 35432025